_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
788211717,9/14/2015 15:01:07,1737925234,9/14/2015 14:59:20,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:04:06,1737926563,9/14/2015 15:03:21,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:07:02,1737927837,9/14/2015 15:06:02,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:07:23,1737927975,9/14/2015 15:05:20,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:13:00,1737930417,9/14/2015 15:12:38,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:13:34,1737930656,9/14/2015 15:12:10,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211717,9/14/2015 15:15:05,1737931302,9/14/2015 15:14:43,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,149,39,,173,50,treats,0.99654575824488,803403,"Hastings RC, Trautman JR, Enna CD et alTHALIDOMIDE in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in ERYTHEMA NODOSUM LEPROSUM.",ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
788211718,9/14/2015 15:33:41,1737940246,9/14/2015 15:33:12,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211718,9/14/2015 15:39:27,1737942889,9/14/2015 15:39:07,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211718,9/14/2015 15:41:43,1737943916,9/14/2015 15:41:21,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211718,9/14/2015 15:43:34,1737944834,9/14/2015 15:43:11,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,no_relation,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211718,9/14/2015 15:51:28,1737949125,9/14/2015 15:47:16,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211718,9/14/2015 15:52:08,1737949430,9/14/2015 15:51:00,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,PATELLO FEMORAL JOINT treats ARTHROSIS OF THE KNEE,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211718,9/14/2015 15:53:46,1737950311,9/14/2015 15:53:08,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,44,109,,64,130,treats,0.337526370277807,902308,The progressive radiological changes in the PATELLO FEMORAL JOINT after upper tibial osteotomy performed for ARTHROSIS OF THE KNEE were studied more than 10 years after the surgical procedure.,PATELLO FEMORAL JOINT,ARTHROSIS OF THE KNEE,RO-disease_has_primary_anatomic_site
788211719,9/14/2015 17:45:55,1738006453,9/14/2015 17:45:38,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:46:01,1738006491,9/14/2015 17:45:52,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:51:09,1738009200,9/14/2015 17:50:44,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:53:18,1738010549,9/14/2015 17:51:55,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,no_relation,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:54:27,1738011043,9/14/2015 17:52:54,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:54:54,1738011301,9/14/2015 17:53:02,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211719,9/14/2015 17:55:12,1738011457,9/14/2015 17:53:55,false,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,WARFARIN treats STROKE,141,41,,146,49,treats,0.964901281354015,804297,A meta analysis of 3 RCTs has shown that WARFARIN given after MI to achieve an international normalized ratio of 2.0 to 3.0 reduced risk for STROKE,STROKE,WARFARIN,TWrex-cause
788211720,9/14/2015 17:46:15,1738006584,9/14/2015 17:46:03,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211720,9/14/2015 17:46:37,1738006713,9/14/2015 17:45:57,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211720,9/14/2015 17:52:15,1738009834,9/14/2015 17:51:10,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211720,9/14/2015 17:54:24,1738011025,9/14/2015 17:53:19,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211720,9/14/2015 17:54:56,1738011344,9/14/2015 17:54:29,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211720,9/14/2015 17:56:10,1738011989,9/14/2015 17:55:23,false,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211720,9/14/2015 17:56:39,1738012261,9/14/2015 17:54:55,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,ETHOSUXIMIDE treats CHILDHOOD ABSENCE EPILEPSY,136,86,,161,98,treats,1,804166,In a study published in the March 2010 Pakistan Journal of Medicine it was found that ETHOSUXIMIDE was the most effective treatment for CHILDHOOD ABSENCE EPILEPSY,CHILDHOOD ABSENCE EPILEPSY,ETHOSUXIMIDE,TWrex-cause
788211721,9/14/2015 17:19:34,1737993569,9/14/2015 17:19:27,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:23:23,1737995633,9/14/2015 17:22:35,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:28:58,1737997939,9/14/2015 17:28:34,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:34:44,1738000806,9/14/2015 17:34:16,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:35:15,1738001046,9/14/2015 17:35:07,false,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:39:09,1738003384,9/14/2015 17:38:48,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,TUBERCULOSIS (TB) treats PYRAZINOIC ACID AMIDE,162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:50:54,1738009077,9/14/2015 17:50:00,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.970494958830946,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211722,9/14/2015 14:50:27,1737920601,9/14/2015 14:50:09,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211722,9/14/2015 14:50:56,1737920770,9/14/2015 14:50:02,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211722,9/14/2015 14:51:58,1737921189,9/14/2015 14:51:39,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211722,9/14/2015 14:52:04,1737921239,9/14/2015 14:51:45,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211722,9/14/2015 14:52:06,1737921265,9/14/2015 14:51:26,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211722,9/14/2015 14:54:35,1737922372,9/14/2015 14:53:56,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211722,9/14/2015 14:56:23,1737923237,9/14/2015 14:53:20,false,neodev,0.6012,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,no_relation,105,59,,128,72,treats,0.78086880944303,907865,A clinical comparison between glipizide (Glibenese ����渇�膩��臂�申�鰹申鐃順�GLIBENCLAMIDEnclamide (Daonil ����渇�膩��臂�申�鰹申鐃順�����渇���申in tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
788211723,9/14/2015 15:21:40,1737934703,9/14/2015 15:21:33,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211723,9/14/2015 15:27:34,1737937122,9/14/2015 15:27:17,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211723,9/14/2015 15:30:13,1737938328,9/14/2015 15:30:06,false,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211723,9/14/2015 15:30:28,1737938449,9/14/2015 15:29:58,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211723,9/14/2015 15:30:47,1737938708,9/14/2015 15:24:19,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211723,9/14/2015 15:30:48,1737938716,9/14/2015 15:29:04,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211723,9/14/2015 15:31:45,1737939188,9/14/2015 15:30:42,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,INTRAVENOUS VERAPAMIL THERAPY treats IMMINENT MYOCARDIAL INFARCTION,70,37,,99,66,treats,0.976092160357725,803527,"Hasin Y, Freiman I, Schwarz T et al. INTRAVENOUS VERAPAMIL THERAPY in IMMINENT MYOCARDIAL INFARCTION",IMMINENT MYOCARDIAL INFARCTION,INTRAVENOUS VERAPAMIL THERAPY,TWrex-cause
788211724,9/14/2015 17:35:59,1738001508,9/14/2015 17:35:35,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS treats TOXIC SHOCK SYNDROME,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211724,9/14/2015 17:41:24,1738004417,9/14/2015 17:40:54,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211724,9/14/2015 17:45:16,1738006138,9/14/2015 17:44:58,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,TOXIC SHOCK SYNDROME treats TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211724,9/14/2015 17:45:36,1738006340,9/14/2015 17:45:10,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,TOXIC SHOCK SYNDROME treats TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211724,9/14/2015 17:49:59,1738008545,9/14/2015 17:47:13,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS treats TOXIC SHOCK SYNDROME,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211724,9/14/2015 17:49:59,1738008567,9/14/2015 17:46:06,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,no_relation,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211724,9/14/2015 17:53:25,1738010612,9/14/2015 17:52:16,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,no_relation,14,35,,33,74,treats,0.342997170285018,810489,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
788211725,9/14/2015 15:27:52,1737937252,9/14/2015 15:27:35,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211725,9/14/2015 15:30:55,1737938783,9/14/2015 15:30:28,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211725,9/14/2015 15:32:12,1737939398,9/14/2015 15:31:45,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,NOCARDIOSIS treats NOCARDIA,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211725,9/14/2015 15:32:15,1737939422,9/14/2015 15:30:49,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,NOCARDIOSIS treats NOCARDIA,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211725,9/14/2015 15:36:15,1737941545,9/14/2015 15:31:50,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,no_relation,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211725,9/14/2015 15:36:36,1737941673,9/14/2015 15:30:48,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,no_relation,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211725,9/14/2015 15:36:52,1737941775,9/14/2015 15:35:59,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,NOCARDIA treats NOCARDIOSIS,65,95,,75,103,treats,0.316227766016838,810975,106  Nocardiosis  Alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA,NOCARDIOSIS,NOCARDIA,TWrex-cause
788211726,9/14/2015 14:59:18,1737924511,9/14/2015 14:58:15,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES treats CMV INFECTION,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211726,9/14/2015 15:03:20,1737926253,9/14/2015 15:02:37,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES treats CMV INFECTION,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211726,9/14/2015 15:05:17,1737927147,9/14/2015 15:04:01,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES treats CMV INFECTION,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211726,9/14/2015 15:06:00,1737927387,9/14/2015 15:04:13,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,CMV INFECTION treats CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211726,9/14/2015 15:12:09,1737929994,9/14/2015 15:11:14,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES treats CMV INFECTION,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211726,9/14/2015 15:12:37,1737930246,9/14/2015 15:11:46,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES treats CMV INFECTION,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211726,9/14/2015 15:14:42,1737931099,9/14/2015 15:14:06,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,CMV INFECTION treats CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,124,58,,136,98,treats,0.997054485501581,811378,intravenous     An immune globulin preparation containing CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES used to treat or prevent CMV INFECTION after organ or tissue transplantation.,CMV INFECTION,CYTOMEGALOVIRUS (CMV SPECIFIC ANTIBODIES,TWrex-cause
788211727,9/14/2015 18:37:07,1738034775,9/14/2015 18:36:37,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:24:58,1738103262,9/14/2015 19:24:42,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:29:19,1738109432,9/14/2015 19:29:09,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:36:38,1738119712,9/14/2015 19:36:13,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:46:37,1738133101,9/14/2015 19:46:18,false,clixsense,0.8333,21665495,CAN,"","",24.105.69.70,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:51:20,1738138927,9/14/2015 19:50:33,false,instagc,1.0,21467491,USA,PA,Erie,24.165.145.54,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:53:00,1738140947,9/14/2015 19:52:41,false,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,82,0,,90,16,treats,0.911322376865767,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211728,9/14/2015 17:55:50,1738011808,9/14/2015 17:55:41,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211728,9/14/2015 18:03:03,1738015374,9/14/2015 18:02:37,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211728,9/14/2015 18:14:51,1738021830,9/14/2015 18:14:28,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211728,9/14/2015 18:23:00,1738026032,9/14/2015 18:22:22,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211728,9/14/2015 18:25:13,1738027490,9/14/2015 18:24:50,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211728,9/14/2015 18:26:54,1738028363,9/14/2015 18:26:47,false,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,PARKINSON'S DISEASE treats LEVODOPA,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211728,9/14/2015 18:35:05,1738033437,9/14/2015 18:33:04,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501581,908327,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788211729,9/14/2015 15:04:27,1737926715,9/14/2015 15:04:07,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:09:22,1737928836,9/14/2015 15:08:39,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,no_relation,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:09:31,1737928905,9/14/2015 15:07:26,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:13:13,1737930496,9/14/2015 15:13:01,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:14:22,1737930954,9/14/2015 15:13:35,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:15:25,1737931461,9/14/2015 15:15:05,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:19:05,1737933472,9/14/2015 15:17:54,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.991836598134175,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211730,9/14/2015 15:01:07,1737925233,9/14/2015 14:59:20,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:04:06,1737926564,9/14/2015 15:03:21,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:07:02,1737927840,9/14/2015 15:06:02,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:07:23,1737927974,9/14/2015 15:05:20,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:13:00,1737930420,9/14/2015 15:12:38,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:13:34,1737930657,9/14/2015 15:12:10,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:15:05,1737931327,9/14/2015 15:14:43,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211731,9/14/2015 15:33:12,1737940015,9/14/2015 15:32:55,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,[DABIGATRAN 110 MG] treats [MAJOR BLEEDING],0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211731,9/14/2015 15:39:07,1737942771,9/14/2015 15:38:17,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211731,9/14/2015 15:41:20,1737943740,9/14/2015 15:41:07,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211731,9/14/2015 15:43:10,1737944674,9/14/2015 15:42:30,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,[DABIGATRAN 110 MG] treats [MAJOR BLEEDING],0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211731,9/14/2015 15:47:14,1737946555,9/14/2015 15:46:59,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211731,9/14/2015 15:50:56,1737948810,9/14/2015 15:50:21,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,[DABIGATRAN 110 MG] treats [MAJOR BLEEDING],0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211731,9/14/2015 15:53:06,1737949985,9/14/2015 15:52:23,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,0,55,,14,71,treats,0.676123403782813,207147,[MAJOR BLEEDING] occurred significantly less often with [DABIGATRAN 110 MG] than warfarin; dabigatran 150 mg had similar bleeding to warfarin.,[MAJOR BLEEDING],[DABIGATRAN 110 MG],TWrex-treat
788211732,9/14/2015 17:55:50,1738011806,9/14/2015 17:55:41,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,DIAZEPAM treats BARBITURATE,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211732,9/14/2015 18:03:03,1738015375,9/14/2015 18:02:37,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,BARBITURATE treats DIAZEPAM,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211732,9/14/2015 18:14:51,1738021832,9/14/2015 18:14:28,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,no_relation,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211732,9/14/2015 18:23:00,1738026031,9/14/2015 18:22:22,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,DIAZEPAM treats BARBITURATE,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211732,9/14/2015 18:25:13,1738027488,9/14/2015 18:24:50,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211732,9/14/2015 18:26:54,1738028358,9/14/2015 18:26:47,false,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,DIAZEPAM treats BARBITURATE,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211732,9/14/2015 18:35:05,1738033436,9/14/2015 18:33:04,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,DIAZEPAM treats BARBITURATE,92,12,,103,20,treats,0.348155311911396,214176,In addition [DIAZEPAM] has been shown to be able to substitute for the behavioural effects of [BARBITURATE]s in a primate study.,BARBITURATE,DIAZEPAM,TWrex-treat
788211733,9/14/2015 14:51:56,1737921181,9/14/2015 14:51:43,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,SERTRALINE treats POSTTRAUMATIC STRESS DISORDER,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211733,9/14/2015 14:52:59,1737921609,9/14/2015 14:52:47,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,SERTRALINE treats POSTTRAUMATIC STRESS DISORDER,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211733,9/14/2015 14:53:17,1737921725,9/14/2015 14:53:05,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,SERTRALINE treats POSTTRAUMATIC STRESS DISORDER,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211733,9/14/2015 14:54:26,1737922289,9/14/2015 14:53:50,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,SERTRALINE treats POSTTRAUMATIC STRESS DISORDER,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211733,9/14/2015 14:56:40,1737923372,9/14/2015 14:56:19,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,POSTTRAUMATIC STRESS DISORDER treats SERTRALINE,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211733,9/14/2015 14:56:45,1737923450,9/14/2015 14:55:31,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,SERTRALINE treats POSTTRAUMATIC STRESS DISORDER,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211733,9/14/2015 14:57:05,1737923590,9/14/2015 14:56:24,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,POSTTRAUMATIC STRESS DISORDER treats SERTRALINE,48,12,,76,22,treats,1,804721,"Efficacy of SERTRALINE in preventing relapse of POSTTRAUMATIC STRESS DISORDER: results of a 28 week double blind, placebo controlled study.",POSTTRAUMATIC STRESS DISORDER,SERTRALINE,TWrex-cause
788211734,9/14/2015 17:41:48,1738004581,9/14/2015 17:41:25,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:45:37,1738006345,9/14/2015 17:45:17,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,PNEUMOCYSTIS PNEUMONIA treats SULFAMETHOXAZOLE,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:45:49,1738006397,9/14/2015 17:45:38,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,SULFAMETHOXAZOLE treats PNEUMOCYSTIS PNEUMONIA,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:50:43,1738009010,9/14/2015 17:49:29,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,no_relation,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:51:54,1738009604,9/14/2015 17:50:56,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,PNEUMOCYSTIS PNEUMONIA treats SULFAMETHOXAZOLE,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:52:53,1738010264,9/14/2015 17:51:14,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,SULFAMETHOXAZOLE treats PNEUMOCYSTIS PNEUMONIA,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211734,9/14/2015 17:53:01,1738010391,9/14/2015 17:50:01,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,SULFAMETHOXAZOLE treats PNEUMOCYSTIS PNEUMONIA,39,129,,61,145,treats,0.949425326555083,218376,It is used prophylactically to prevent [PNEUMOCYSTIS PNEUMONIA] and toxoplasmosis in patients unable to tolerate trimethoprim with [SULFAMETHOXAZOLE].,PNEUMOCYSTIS PNEUMONIA,SULFAMETHOXAZOLE,TWrex-treat
788211735,9/14/2015 15:55:58,1737951360,9/14/2015 15:55:35,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:08:39,1737957517,9/14/2015 16:08:27,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,VISCERAL LEISHMANIASIS treats LIPOSOMAL AMPHOTERICIN B,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:09:08,1737957864,9/14/2015 16:08:21,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:15:29,1737960576,9/14/2015 16:15:08,false,clixsense,0.8958,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:20:45,1737963572,9/14/2015 16:20:29,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:33:39,1737969641,9/14/2015 16:33:03,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211735,9/14/2015 16:34:42,1737970180,9/14/2015 16:33:56,false,elite,0.25,33798502,USA,DE,"",108.59.8.218,LIPOSOMAL AMPHOTERICIN B treats VISCERAL LEISHMANIASIS,70,98,,91,122,treats,0.990147542976674,800170,"Davidson RN, di Martino L, Gradoni L et al. Short course treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B (AmBisome.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B,TWrex-cause
788211736,9/14/2015 17:19:01,1737993262,9/14/2015 17:18:44,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211736,9/14/2015 17:20:40,1737994261,9/14/2015 17:20:04,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211736,9/14/2015 17:24:24,1737996031,9/14/2015 17:24:14,false,clixsense,0.9286,21490235,GBR,N7,Woking,86.30.254.232,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211736,9/14/2015 17:25:11,1737996347,9/14/2015 17:25:01,false,instagc,0.9286,13581319,USA,IL,Trenton,208.70.36.12,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211736,9/14/2015 17:25:17,1737996382,9/14/2015 17:24:51,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211736,9/14/2015 17:28:21,1737997663,9/14/2015 17:28:08,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211736,9/14/2015 17:33:59,1738000392,9/14/2015 17:33:23,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,INSULIN SECRETAGOGUES treats TYPE 2 DIABETES,53,11,,67,32,treats,0.997458699830735,907897,The use of INSULIN SECRETAGOGUES in the treatment of TYPE 2 DIABETES,TYPE 2 DIABETES,INSULIN SECRETAGOGUES,RO-may_treat
788211737,9/14/2015 17:46:15,1738006583,9/14/2015 17:46:03,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211737,9/14/2015 17:46:37,1738006710,9/14/2015 17:45:57,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,no_relation,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211737,9/14/2015 17:52:15,1738009833,9/14/2015 17:51:10,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211737,9/14/2015 17:54:24,1738011019,9/14/2015 17:53:19,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211737,9/14/2015 17:54:56,1738011342,9/14/2015 17:54:29,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211737,9/14/2015 17:56:10,1738011990,9/14/2015 17:55:23,false,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,no_relation,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211737,9/14/2015 17:56:39,1738012260,9/14/2015 17:54:55,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,CANDESARTAN CILEXETIL treats HYPERTENSION,117,61,,128,82,treats,0.962250448649376,907902,"Sever P, Holzgreve H. Long term efficacy and tolerability of CANDESARTAN CILEXETIL in patients with mild to moderate HYPERTENSION",HYPERTENSION,CANDESARTAN CILEXETIL,RO-may_treat
788211738,9/14/2015 17:19:34,1737993568,9/14/2015 17:19:27,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:23:23,1737995636,9/14/2015 17:22:35,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:28:58,1737997937,9/14/2015 17:28:34,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:34:44,1738000764,9/14/2015 17:34:16,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:35:15,1738001049,9/14/2015 17:35:07,false,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:39:09,1738003385,9/14/2015 17:38:48,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211738,9/14/2015 17:50:54,1738009078,9/14/2015 17:50:00,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,WARFARIN treats PULMONARY EMBOLISM,93,137,,111,145,treats,0.98058067569092,907168,Clinical trials are currently investigating the potential value of LMWHs in the treatment of PULMONARY EMBOLISM and as an alternative to WARFARIN in secondary prevention of DVT,PULMONARY EMBOLISM,WARFARIN,RO-may_prevent
788211739,9/14/2015 16:09:29,1737958027,9/14/2015 16:09:18,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:22:01,1737964086,9/14/2015 16:21:42,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:45:53,1737975651,9/14/2015 16:45:35,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:46:04,1737975737,9/14/2015 16:45:28,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:48:51,1737977225,9/14/2015 16:46:17,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 16:55:04,1737980539,9/14/2015 16:54:46,false,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211739,9/14/2015 17:05:46,1737986597,9/14/2015 17:05:31,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1,906775,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
788211740,9/14/2015 18:36:36,1738034496,9/14/2015 18:35:55,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,no_relation,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211740,9/14/2015 18:39:11,1738036936,9/14/2015 18:38:48,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,RANS RETINOIC ACID I treats PL I,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211740,9/14/2015 19:24:41,1738102866,9/14/2015 19:24:12,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,RANS RETINOIC ACID I treats PL I,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211740,9/14/2015 19:29:09,1738109181,9/14/2015 19:28:58,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,RANS RETINOIC ACID I treats PL I,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211740,9/14/2015 19:36:08,1738118806,9/14/2015 19:35:38,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,RANS RETINOIC ACID I treats PL I,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211740,9/14/2015 19:46:18,1738132668,9/14/2015 19:45:27,false,clixsense,0.8333,21665495,CAN,"","",24.105.69.70,RANS RETINOIC ACID I treats PL I,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211740,9/14/2015 19:52:40,1738140561,9/14/2015 19:49:41,false,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,53,14,,56,34,treats,0.970494958830946,803576, Include all tRANS RETINOIC ACID In the therapy for APL In induction combined with multiple courses of post remission chemotherapy ('4+2' or arsenic trioxide) to eradicate minimal residual disease,PL I,RANS RETINOIC ACID I,TWrex-cause
788211741,9/14/2015 15:21:32,1737934599,9/14/2015 15:21:10,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,SALMONELLA TYPHI treats TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211741,9/14/2015 15:24:18,1737935730,9/14/2015 15:23:23,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,no_relation,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211741,9/14/2015 15:27:16,1737936993,9/14/2015 15:26:58,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211741,9/14/2015 15:29:02,1737937808,9/14/2015 15:27:37,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,SALMONELLA TYPHI treats TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211741,9/14/2015 15:29:57,1737938223,9/14/2015 15:29:25,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211741,9/14/2015 15:30:04,1737938258,9/14/2015 15:29:48,false,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS treats SALMONELLA TYPHI,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211741,9/14/2015 15:31:49,1737939206,9/14/2015 15:28:50,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,no_relation,5,141,,38,157,treats,0.344123600805843,810843,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI,TWrex-cause
788211742,9/14/2015 15:28:15,1737937435,9/14/2015 15:27:53,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211742,9/14/2015 15:31:21,1737939030,9/14/2015 15:30:57,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211742,9/14/2015 15:32:38,1737939692,9/14/2015 15:32:12,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211742,9/14/2015 15:33:17,1737940088,9/14/2015 15:32:16,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211742,9/14/2015 15:37:54,1737942332,9/14/2015 15:37:19,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211742,9/14/2015 15:40:35,1737943425,9/14/2015 15:39:59,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211742,9/14/2015 15:49:31,1737947930,9/14/2015 15:41:15,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,93,30,,107,52,treats,0.832050294337844,800894,Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211743,9/14/2015 18:03:12,1738015425,9/14/2015 18:03:04,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:15:14,1738022006,9/14/2015 18:14:52,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,no_relation,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:23:46,1738026560,9/14/2015 18:23:00,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:25:47,1738027824,9/14/2015 18:25:15,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:27:03,1738028433,9/14/2015 18:26:57,false,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:34:28,1738033078,9/14/2015 18:33:45,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,no_relation,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211743,9/14/2015 18:36:08,1738033983,9/14/2015 18:35:06,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,AMPHOTERICIN B treats NEUTROPENIA,195,128,,205,142,treats,0.911684611677104,800301,"1]  Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with AMPHOTERICIN B for the treatment of candidemia in patients without NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
788211744,9/14/2015 14:51:19,1737920916,9/14/2015 14:50:58,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211744,9/14/2015 14:52:34,1737921415,9/14/2015 14:52:21,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211744,9/14/2015 14:52:43,1737921495,9/14/2015 14:52:27,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211744,9/14/2015 14:52:50,1737921549,9/14/2015 14:51:40,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211744,9/14/2015 14:54:29,1737922312,9/14/2015 14:53:18,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211744,9/14/2015 14:55:52,1737922947,9/14/2015 14:55:19,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,GRAFT VERSUS HOST DISEASE treats CYCLOSPORINE,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211744,9/14/2015 14:56:23,1737923247,9/14/2015 14:55:04,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,CYCLOSPORINE treats GRAFT VERSUS HOST DISEASE,40,153,,64,165,treats,0.940720868383597,804679,"Nash RA, Pepe MS, Storb R, et al: Acute GRAFT VERSUS HOST DISEASE: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with CYCLOSPORINE and methotrexate.",GRAFT VERSUS HOST DISEASE,CYCLOSPORINE,TWrex-cause
788211745,9/14/2015 16:09:17,1737957936,9/14/2015 16:09:01,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,ALPRAZOLAM treats PANIC DISORDER,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211745,9/14/2015 16:10:27,1737958460,9/14/2015 16:09:42,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,ALPRAZOLAM treats PANIC DISORDER,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211745,9/14/2015 16:21:42,1737963977,9/14/2015 16:21:12,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,ALPRAZOLAM treats PANIC DISORDER,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211745,9/14/2015 16:35:10,1737970463,9/14/2015 16:35:02,false,elite,0.25,33798502,USA,DE,"",108.59.8.218,PANIC DISORDER treats ALPRAZOLAM,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211745,9/14/2015 16:45:27,1737975434,9/14/2015 16:44:42,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,ALPRAZOLAM treats PANIC DISORDER,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211745,9/14/2015 16:45:34,1737975493,9/14/2015 16:45:11,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,ALPRAZOLAM treats PANIC DISORDER,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211745,9/14/2015 16:46:16,1737975826,9/14/2015 16:44:41,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,ALPRAZOLAM treats PANIC DISORDER,131,86,,144,96,treats,0.997458699830735,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short term ALPRAZOLAM and behavioral group treatment of PANIC DISORDER",PANIC DISORDER,ALPRAZOLAM,TWrex-cause
788211746,9/14/2015 14:51:56,1737921193,9/14/2015 14:51:43,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:52:59,1737921610,9/14/2015 14:52:47,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:53:17,1737921726,9/14/2015 14:53:05,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:54:26,1737922291,9/14/2015 14:53:50,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:56:40,1737923375,9/14/2015 14:56:19,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:56:45,1737923441,9/14/2015 14:55:31,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211746,9/14/2015 14:57:05,1737923593,9/14/2015 14:56:24,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,UROKINASE THERAPY treats CLINICAL PULMONARY EMBOLISM,63,42,,89,59,treats,0.995037190209989,800311,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY,TWrex-cause
788211747,9/14/2015 17:46:56,1738006893,9/14/2015 17:46:38,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,BENIGN PROSTATIC HYPERPLASIA treats FINASTERIDE,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 17:55:27,1738011611,9/14/2015 17:54:57,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 17:55:37,1738011726,9/14/2015 17:54:25,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 17:56:53,1738012409,9/14/2015 17:56:11,false,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 18:02:21,1738015046,9/14/2015 18:01:46,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,BENIGN PROSTATIC HYPERPLASIA treats FINASTERIDE,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 18:12:56,1738020903,9/14/2015 18:12:32,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211747,9/14/2015 18:21:35,1738025325,9/14/2015 18:20:01,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,FINASTERIDE treats BENIGN PROSTATIC HYPERPLASIA,101,85,,128,96,treats,0.99654575824488,804571,"Kaplan SA, McConnell JD, Roehrborn CG, et al: Combination therapy with doxazosin and FINASTERIDE for BENIGN PROSTATIC HYPERPLASIA in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater.",BENIGN PROSTATIC HYPERPLASIA,FINASTERIDE,TWrex-cause
788211748,9/14/2015 15:45:11,1737945470,9/14/2015 15:44:50,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,no_relation,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 15:52:28,1737949609,9/14/2015 15:52:12,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 15:55:33,1737951195,9/14/2015 15:54:51,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:08:19,1737957373,9/14/2015 16:07:15,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:08:25,1737957446,9/14/2015 16:07:49,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,CLOSTRIDIUM PERFRINGENS treats CLOSTRIDIUM INFECTIONS,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:15:07,1737960494,9/14/2015 16:14:18,false,clixsense,0.8958,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,no_relation,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:20:28,1737963490,9/14/2015 16:20:02,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,4,63,,25,86,treats,0.398233986959983,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211749,9/14/2015 15:17:09,1737932509,9/14/2015 15:16:43,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211749,9/14/2015 15:20:54,1737934219,9/14/2015 15:20:40,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,ASPIRIN treats MYOCARDIAL INFARCTION,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211749,9/14/2015 15:21:55,1737934860,9/14/2015 15:20:23,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,ASPIRIN treats MYOCARDIAL INFARCTION,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211749,9/14/2015 15:22:57,1737935246,9/14/2015 15:21:53,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,no_relation,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211749,9/14/2015 15:25:49,1737936368,9/14/2015 15:22:21,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,ASPIRIN treats MYOCARDIAL INFARCTION,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211749,9/14/2015 15:26:26,1737936714,9/14/2015 15:25:45,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,ASPIRIN treats MYOCARDIAL INFARCTION,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211749,9/14/2015 15:37:18,1737941978,9/14/2015 15:36:53,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,71,108,,91,115,treats,0.923380516876639,805226,"The most appropriate role of warfarin for secondary prevention after a MYOCARDIAL INFARCTION in patients on ASPIRIN remains unclear, especially since the widespread use of dual antiplatelet therapy, and particularly given the availability of new, more potent P2Y12 inhibitors that are on the horizon.",MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
788211750,9/14/2015 16:09:17,1737957934,9/14/2015 16:09:01,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:10:27,1737958456,9/14/2015 16:09:42,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:21:42,1737963987,9/14/2015 16:21:12,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:35:10,1737970462,9/14/2015 16:35:02,false,elite,0.25,33798502,USA,DE,"",108.59.8.218,COCCIDIOIDOMYCOSIS treats AMPHOTERICIN B,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:45:27,1737975440,9/14/2015 16:44:42,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:45:34,1737975495,9/14/2015 16:45:11,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:46:16,1737975824,9/14/2015 16:44:41,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.943456353049727,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211751,9/14/2015 14:59:18,1737924509,9/14/2015 14:58:15,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,NICOTINE treats NICOTINE ADDICTION,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211751,9/14/2015 15:03:20,1737926254,9/14/2015 15:02:37,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211751,9/14/2015 15:05:17,1737927146,9/14/2015 15:04:01,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211751,9/14/2015 15:06:00,1737927363,9/14/2015 15:04:13,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,NICOTINE ADDICTION treats NICOTINE,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211751,9/14/2015 15:12:09,1737929989,9/14/2015 15:11:14,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211751,9/14/2015 15:12:37,1737930245,9/14/2015 15:11:46,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211751,9/14/2015 15:14:42,1737931104,9/14/2015 15:14:06,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,79,20,,97,28,treats,0.577350269189626,400310,Vaccination against NICOTINE represents a promising novel concept for treating NICOTINE ADDICTION,NICOTINE ADDICTION,NICOTINE,TWrex-cause
788211752,9/14/2015 19:29:38,1738109870,9/14/2015 19:29:20,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211752,9/14/2015 19:36:59,1738120153,9/14/2015 19:36:39,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211752,9/14/2015 19:47:17,1738133897,9/14/2015 19:46:38,false,clixsense,0.8333,21665495,CAN,"","",24.105.69.70,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211752,9/14/2015 19:54:29,1738142796,9/14/2015 19:53:02,false,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211752,9/14/2015 19:56:20,1738144931,9/14/2015 19:53:39,false,neodev,0.7,11658682,CAN,BC,Smithers,50.98.182.88,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211752,9/14/2015 20:00:21,1738149946,9/14/2015 19:59:26,false,elite,0.8,29768955,GBR,C3,Gamlingay,31.50.187.165,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211752,9/14/2015 20:39:51,1738222276,9/14/2015 20:39:20,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,NICARDIPINE treats HYPERTENSION,95,45,,106,56,treats,0.99124070716193,803696,"1]  Jannet D, Carbonne B, Sebban E, Milliez JNICARDIPINE versus metoprolol in the treatment of HYPERTENSION during pregnancy: a randomized comparative trial.",HYPERTENSION,NICARDIPINE,TWrex-cause
788211753,9/14/2015 18:24:49,1738027213,9/14/2015 18:23:46,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 18:26:33,1738028137,9/14/2015 18:25:48,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 18:35:00,1738033346,9/14/2015 18:34:28,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 18:36:59,1738034722,9/14/2015 18:36:09,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 19:23:28,1738101021,9/14/2015 19:23:08,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 19:26:20,1738105351,9/14/2015 19:24:00,false,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211753,9/14/2015 19:35:38,1738118144,9/14/2015 19:35:17,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,PENICILLIN G BENZATHINE treats RHEUMATIC FEVER,119,157,,133,180,treats,0.984731927834662,800843,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE,TWrex-cause
788211754,9/14/2015 18:03:12,1738015420,9/14/2015 18:03:04,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,OSTEOARTHRITIS treats PIROXICAM,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211754,9/14/2015 18:15:14,1738022007,9/14/2015 18:14:52,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,PIROXICAM treats OSTEOARTHRITIS,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211754,9/14/2015 18:23:46,1738026558,9/14/2015 18:23:00,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,no_relation,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211754,9/14/2015 18:25:47,1738027823,9/14/2015 18:25:15,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,PIROXICAM treats OSTEOARTHRITIS,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211754,9/14/2015 18:27:03,1738028431,9/14/2015 18:26:57,false,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,PIROXICAM treats OSTEOARTHRITIS,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211754,9/14/2015 18:34:28,1738033074,9/14/2015 18:33:45,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,PIROXICAM treats OSTEOARTHRITIS,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211754,9/14/2015 18:36:08,1738033999,9/14/2015 18:35:06,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,PIROXICAM treats OSTEOARTHRITIS,71,29,,84,38,treats,0.997458699830735,804217,Double blind study comparing PIROXICAM and aspirin in the treatment of OSTEOARTHRITIS,OSTEOARTHRITIS,PIROXICAM,TWrex-cause
788211755,9/14/2015 15:21:32,1737934603,9/14/2015 15:21:10,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211755,9/14/2015 15:24:18,1737935728,9/14/2015 15:23:23,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211755,9/14/2015 15:27:16,1737936992,9/14/2015 15:26:58,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211755,9/14/2015 15:29:02,1737937805,9/14/2015 15:27:37,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211755,9/14/2015 15:29:57,1737938225,9/14/2015 15:29:25,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211755,9/14/2015 15:30:04,1737938261,9/14/2015 15:29:48,false,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211755,9/14/2015 15:31:49,1737939210,9/14/2015 15:28:50,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,WARFARIN treats VTE,78,112,,80,120,treats,0.997458699830735,804760,"This finding was verified by Meschengieser and colleagues (4), who found that VTE events could be controlled by WARFARIN with lower target INR plus low dose aspirin.",VTE,WARFARIN,TWrex-cause
788211756,9/14/2015 15:42:19,1737944267,9/14/2015 15:41:43,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:44:01,1737945015,9/14/2015 15:43:35,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:51:52,1737949281,9/14/2015 15:51:29,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:52:43,1737949719,9/14/2015 15:52:12,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:54:23,1737950637,9/14/2015 15:53:47,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 16:06:08,1737956362,9/14/2015 16:05:05,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 16:07:48,1737957124,9/14/2015 16:07:17,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211757,9/14/2015 15:31:46,1737939178,9/14/2015 15:31:22,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,DALTEPARIN treats MYOCARDIAL INFARCTION,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211757,9/14/2015 15:32:54,1737939889,9/14/2015 15:32:39,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,DALTEPARIN treats MYOCARDIAL INFARCTION,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211757,9/14/2015 15:38:17,1737942467,9/14/2015 15:37:55,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,DALTEPARIN treats MYOCARDIAL INFARCTION,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211757,9/14/2015 15:41:06,1737943626,9/14/2015 15:40:36,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211757,9/14/2015 15:42:30,1737944317,9/14/2015 15:41:52,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,DALTEPARIN treats MYOCARDIAL INFARCTION,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211757,9/14/2015 15:46:58,1737946401,9/14/2015 15:46:07,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211757,9/14/2015 15:50:15,1737948400,9/14/2015 15:49:35,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,DALTEPARIN treats MYOCARDIAL INFARCTION,120,91,,140,101,treats,0.98058067569092,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and MYOCARDIAL INFARCTION at 1 month but not at 3 months.",MYOCARDIAL INFARCTION,DALTEPARIN,TWrex-cause
788211758,9/14/2015 15:31:46,1737939181,9/14/2015 15:31:22,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211758,9/14/2015 15:32:54,1737939894,9/14/2015 15:32:39,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211758,9/14/2015 15:38:17,1737942470,9/14/2015 15:37:55,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211758,9/14/2015 15:41:06,1737943618,9/14/2015 15:40:36,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211758,9/14/2015 15:42:30,1737944308,9/14/2015 15:41:52,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,no_relation,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211758,9/14/2015 15:46:58,1737946408,9/14/2015 15:46:07,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211758,9/14/2015 15:50:15,1737948392,9/14/2015 15:49:35,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,PV treats THROMBOSIS,96,16,,105,18,treats,0.333333333333333,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
788211759,9/14/2015 15:33:41,1737940249,9/14/2015 15:33:12,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211759,9/14/2015 15:39:27,1737942884,9/14/2015 15:39:07,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211759,9/14/2015 15:41:43,1737943918,9/14/2015 15:41:21,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211759,9/14/2015 15:43:34,1737944832,9/14/2015 15:43:11,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211759,9/14/2015 15:51:28,1737949093,9/14/2015 15:47:16,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211759,9/14/2015 15:52:08,1737949419,9/14/2015 15:51:00,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211759,9/14/2015 15:53:46,1737950312,9/14/2015 15:53:08,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,PROMETHAZINE treats VOMITING,82,147,,89,159,treats,0.927172649945531,907661,"Prochlorperazine was more effective than promethazine in uncomplicated nausea and VOMITING in the emergency department  Keywords: Prochlorperazine PROMETHAZINE Treatment, emergency.",VOMITING,PROMETHAZINE,RO-may_treat
788211760,9/14/2015 18:36:36,1738034497,9/14/2015 18:35:55,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,DOPAMINE treats SHOCK,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211760,9/14/2015 18:39:11,1738036940,9/14/2015 18:38:48,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,DOPAMINE treats SHOCK,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211760,9/14/2015 19:24:41,1738102871,9/14/2015 19:24:12,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,DOPAMINE treats SHOCK,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211760,9/14/2015 19:29:09,1738109180,9/14/2015 19:28:58,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,DOPAMINE treats SHOCK,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211760,9/14/2015 19:36:08,1738118803,9/14/2015 19:35:38,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,DOPAMINE treats SHOCK,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211760,9/14/2015 19:46:18,1738132672,9/14/2015 19:45:27,false,clixsense,0.8333,21665495,CAN,"","",24.105.69.70,SHOCK treats DOPAMINE,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211760,9/14/2015 19:52:40,1738140554,9/14/2015 19:49:41,false,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,DOPAMINE treats SHOCK,196,244,,200,252,treats,0.976092160357725,804304,Current guidelines recommend that norepinephrine or dopamine be used as the initial vasopressor in patients with septic shock and that epinephrine be used as the first chosen alternative agent if SHOCK is poorly responsive to norepinephrine or DOPAMINE ( 39.,SHOCK,DOPAMINE,TWrex-cause
788211761,9/14/2015 15:05:10,1737927061,9/14/2015 15:04:28,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211761,9/14/2015 15:10:11,1737929078,9/14/2015 15:09:23,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,no_relation,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211761,9/14/2015 15:13:31,1737930648,9/14/2015 15:13:14,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211761,9/14/2015 15:15:00,1737931245,9/14/2015 15:14:23,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211761,9/14/2015 15:15:18,1737931395,9/14/2015 15:11:41,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211761,9/14/2015 15:16:17,1737931966,9/14/2015 15:15:25,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211761,9/14/2015 15:20:22,1737933964,9/14/2015 15:18:41,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,SERTRALINE treats DEPRESSION,137,14,,146,24,treats,0.938314863256837,907692,"Bupropion SR, SERTRALINE or venlafaxine XR after failure of SSRIs for depression  Medication augmentation after the failure of SSRIs for DEPRESSION.",DEPRESSION,SERTRALINE,RO-may_treat
788211762,9/14/2015 14:50:01,1737920396,9/14/2015 14:47:14,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211762,9/14/2015 14:50:09,1737920455,9/14/2015 14:49:36,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211762,9/14/2015 14:51:25,1737920951,9/14/2015 14:50:12,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211762,9/14/2015 14:51:39,1737921095,9/14/2015 14:51:08,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211762,9/14/2015 14:51:44,1737921116,9/14/2015 14:51:07,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211762,9/14/2015 14:54:53,1737922539,9/14/2015 14:52:03,false,neodev,0.7,11314968,CAN,BC,"",173.180.132.26,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211762,9/14/2015 15:02:10,1737925780,9/14/2015 15:01:09,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,SIMVASTATIN treats HYPERCHOLESTEROLEMIA,53,107,,73,118,treats,1,907900,"Tikkanen MJ, Laakso M, Ilmonen M et al. Treatment of HYPERCHOLESTEROLEMIA and combined hyperlipidemia with SIMVASTATIN and gemfibrozil in patients with NIDDM",HYPERCHOLESTEROLEMIA,SIMVASTATIN,RO-may_treat
788211763,9/14/2015 15:21:10,1737934388,9/14/2015 15:20:55,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,NOCARDIA treats NOCARDIA INFECTIONS,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211763,9/14/2015 15:23:22,1737935399,9/14/2015 15:21:55,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,no_relation,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211763,9/14/2015 15:26:57,1737936874,9/14/2015 15:26:27,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211763,9/14/2015 15:27:36,1737937139,9/14/2015 15:25:50,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,NOCARDIA treats NOCARDIA INFECTIONS,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211763,9/14/2015 15:28:49,1737937697,9/14/2015 15:22:58,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,no_relation,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211763,9/14/2015 15:29:24,1737937947,9/14/2015 15:28:28,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211763,9/14/2015 15:29:42,1737938071,9/14/2015 15:29:29,false,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,NOCARDIA treats NOCARDIA INFECTIONS,21,21,,39,29,treats,0.606779876216918,811473,"4 ,   5 ,   6 ,   9  NOCARDIA INFECTIONS  Treatment of infections caused by  NOCARDIA    +.",NOCARDIA INFECTIONS,NOCARDIA,TWrex-cause
788211764,9/14/2015 17:19:01,1737993255,9/14/2015 17:18:44,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211764,9/14/2015 17:20:40,1737994257,9/14/2015 17:20:04,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211764,9/14/2015 17:24:24,1737996029,9/14/2015 17:24:14,false,clixsense,0.9286,21490235,GBR,N7,Woking,86.30.254.232,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211764,9/14/2015 17:25:11,1737996346,9/14/2015 17:25:01,false,instagc,0.9286,13581319,USA,IL,Trenton,208.70.36.12,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211764,9/14/2015 17:25:17,1737996377,9/14/2015 17:24:51,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211764,9/14/2015 17:28:21,1737997662,9/14/2015 17:28:08,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211764,9/14/2015 17:33:59,1738000385,9/14/2015 17:33:23,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,IBUPROFEN treats INFLAMMATION,103,36,,114,45,treats,0.993127066322842,908220,"The evidence for modes of action of IBUPROFEN are considered in relation to its actions in controlling INFLAMMATION pain and fever, as well as the adverse effects of the drug.",INFLAMMATION,IBUPROFEN,RO-may_treat
788211765,9/14/2015 15:21:10,1737934387,9/14/2015 15:20:55,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,TUBERCULIN SKIN TEST treats TUBERCULOSIS,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:23:22,1737935406,9/14/2015 15:21:55,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,no_relation,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:26:57,1737936883,9/14/2015 15:26:27,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:27:36,1737937140,9/14/2015 15:25:50,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,TUBERCULIN SKIN TEST treats TUBERCULOSIS,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:28:49,1737937689,9/14/2015 15:22:58,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,no_relation,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:29:24,1737937953,9/14/2015 15:28:28,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:29:42,1737938070,9/14/2015 15:29:29,false,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,TUBERCULOSIS treats TUBERCULIN SKIN TEST,13,78,,24,98,treats,0.428571428571429,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211766,9/14/2015 18:28:29,1738029267,9/14/2015 18:28:08,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211766,9/14/2015 18:35:54,1738033850,9/14/2015 18:35:24,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY treats HYPERTENSION,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211766,9/14/2015 18:38:46,1738036493,9/14/2015 18:38:31,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY treats HYPERTENSION,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211766,9/14/2015 19:24:11,1738102021,9/14/2015 19:23:54,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY treats HYPERTENSION,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211766,9/14/2015 19:28:14,1738108035,9/14/2015 19:27:41,false,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY treats HYPERTENSION,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211766,9/14/2015 19:28:57,1738108933,9/14/2015 19:28:44,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,HYPERTENSION treats ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211766,9/14/2015 19:35:16,1738117584,9/14/2015 19:34:53,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY treats HYPERTENSION,140,9,,151,58,treats,0.994134846772434,804575,1  >     ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY for Dyslipidemias and Prevention of Cardiovascular Events (Atorvastatin) and for HYPERTENSION and/or CAD (Amlodipine)  Oral:  Use the fixed combination as a  substitute  for the individually titrated drugs.,HYPERTENSION,ATORVASTATIN/AMLODIPINE FIXED COMBINATION THERAPY,TWrex-cause
788211767,9/14/2015 18:37:07,1738034780,9/14/2015 18:36:37,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:24:58,1738103261,9/14/2015 19:24:42,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:29:19,1738109424,9/14/2015 19:29:09,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:36:38,1738119717,9/14/2015 19:36:13,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:46:37,1738133097,9/14/2015 19:46:18,false,clixsense,0.8333,21665495,CAN,"","",24.105.69.70,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:51:20,1738138926,9/14/2015 19:50:33,false,instagc,1.0,21467491,USA,PA,Erie,24.165.145.54,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211767,9/14/2015 19:53:00,1738140946,9/14/2015 19:52:41,false,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,TRIMETHOPRIM SULFAMETHOXAZOLE treats URINARY TRACT INFECTIONS,143,97,,166,126,treats,0.970142500145332,800514,"Allais JM, Preheim LC, Cuevas TA et al. Randomized, double blind comparison of ciprofloxacin and TRIMETHOPRIM SULFAMETHOXAZOLE for complicated URINARY TRACT INFECTIONS",URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE,TWrex-cause
788211768,9/14/2015 14:51:19,1737920920,9/14/2015 14:50:58,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,SERTRALINE treats OBSESSIVE COMPULSIVE DISORDER,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211768,9/14/2015 14:52:34,1737921416,9/14/2015 14:52:21,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,SERTRALINE treats OBSESSIVE COMPULSIVE DISORDER,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211768,9/14/2015 14:52:43,1737921490,9/14/2015 14:52:27,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,SERTRALINE treats OBSESSIVE COMPULSIVE DISORDER,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211768,9/14/2015 14:52:50,1737921547,9/14/2015 14:51:40,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,SERTRALINE treats OBSESSIVE COMPULSIVE DISORDER,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211768,9/14/2015 14:54:29,1737922311,9/14/2015 14:53:18,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,SERTRALINE treats OBSESSIVE COMPULSIVE DISORDER,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211768,9/14/2015 14:55:52,1737922948,9/14/2015 14:55:19,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,SERTRALINE treats OBSESSIVE COMPULSIVE DISORDER,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211768,9/14/2015 14:56:23,1737923249,9/14/2015 14:55:04,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,OBSESSIVE COMPULSIVE DISORDER treats SERTRALINE,92,38,,120,48,treats,1,800366,"Wolkow R, Alderman J, Johnston J et alSERTRALINE treatment of children and adolescents with OBSESSIVE COMPULSIVE DISORDER or depression.",OBSESSIVE COMPULSIVE DISORDER,SERTRALINE,TWrex-cause
788211769,9/14/2015 16:46:09,1737975773,9/14/2015 16:45:55,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 16:46:31,1737975904,9/14/2015 16:46:05,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 16:49:28,1737977659,9/14/2015 16:48:52,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 16:55:11,1737980606,9/14/2015 16:55:06,false,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,TYPE 1 DIABETES treats ACTING INSULIN ANALOG LISPRO,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 17:05:59,1737986714,9/14/2015 17:05:47,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 17:12:53,1737990139,9/14/2015 17:12:09,false,superrewards,0.8583,33199643,USA,WI,La Crosse,138.49.1.27,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 17:21:20,1737994696,9/14/2015 17:20:40,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211770,9/14/2015 16:46:09,1737975782,9/14/2015 16:45:55,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211770,9/14/2015 16:46:31,1737975896,9/14/2015 16:46:05,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211770,9/14/2015 16:49:28,1737977658,9/14/2015 16:48:52,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211770,9/14/2015 16:55:11,1737980605,9/14/2015 16:55:06,false,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211770,9/14/2015 17:05:59,1737986713,9/14/2015 17:05:47,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211770,9/14/2015 17:12:53,1737990137,9/14/2015 17:12:09,false,superrewards,0.8583,33199643,USA,WI,La Crosse,138.49.1.27,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211770,9/14/2015 17:21:20,1737994715,9/14/2015 17:20:40,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,ACEBUTOLOL treats HYPERTENSION,41,14,,52,24,treats,0.997054485501581,907499,Aldactone and ACEBUTOLOL in treatment of HYPERTENSION,HYPERTENSION,ACEBUTOLOL,RO-may_treat
788211771,9/14/2015 18:24:49,1738027225,9/14/2015 18:23:46,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 18:26:33,1738028138,9/14/2015 18:25:48,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 18:35:00,1738033345,9/14/2015 18:34:28,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 18:36:59,1738034723,9/14/2015 18:36:09,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 19:23:28,1738101019,9/14/2015 19:23:08,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 19:26:20,1738105350,9/14/2015 19:24:00,false,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211771,9/14/2015 19:35:38,1738118150,9/14/2015 19:35:17,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,[PREDNISOLONE 60 MG DAILY] treats [PERICARDITIS],13,29,,24,52,treats,0.993127066322842,222045,The dose for [PERICARDITIS] is [PREDNISOLONE 60 MG DAILY] tapered off over four to eight weeks.,[PERICARDITIS],[PREDNISOLONE 60 MG DAILY],TWrex-treat
788211772,9/14/2015 16:09:29,1737958012,9/14/2015 16:09:18,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:22:01,1737964078,9/14/2015 16:21:42,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:45:53,1737975652,9/14/2015 16:45:35,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:46:04,1737975736,9/14/2015 16:45:28,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:48:51,1737977231,9/14/2015 16:46:17,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 16:55:04,1737980534,9/14/2015 16:54:46,false,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211772,9/14/2015 17:05:46,1737986595,9/14/2015 17:05:31,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,SINGLE DOSE OFLOXACIN treats UNCOMPLICATED GONORRHOEA,71,33,,94,54,treats,1,803453,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN,TWrex-cause
788211773,9/14/2015 14:57:00,1737923558,9/14/2015 14:56:42,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211773,9/14/2015 14:58:13,1737924089,9/14/2015 14:57:08,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211773,9/14/2015 15:02:36,1737925913,9/14/2015 15:01:44,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211773,9/14/2015 15:08:38,1737928544,9/14/2015 15:07:07,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211773,9/14/2015 15:11:14,1737929537,9/14/2015 15:10:24,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211773,9/14/2015 15:11:38,1737929771,9/14/2015 15:09:37,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211773,9/14/2015 15:13:47,1737930717,9/14/2015 15:13:31,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,LOVASTATIN treats PRIMARY MODERATE HYPERCHOLESTEROLEMIA,13,56,,49,66,treats,0.983078304622849,907635,Treatment of PRIMARY MODERATE HYPERCHOLESTEROLEMIA with LOVASTATIN (mevinolin) and colestipol.,PRIMARY MODERATE HYPERCHOLESTEROLEMIA,LOVASTATIN,RO-may_treat
788211774,9/14/2015 16:46:39,1737975954,9/14/2015 16:46:10,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211774,9/14/2015 16:47:41,1737976595,9/14/2015 16:46:32,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211774,9/14/2015 16:49:39,1737977756,9/14/2015 16:49:30,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211774,9/14/2015 17:06:13,1737986826,9/14/2015 17:05:59,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211774,9/14/2015 17:13:01,1737990209,9/14/2015 17:12:54,false,superrewards,0.8583,33199643,USA,WI,La Crosse,138.49.1.27,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211774,9/14/2015 17:18:28,1737992851,9/14/2015 17:18:00,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211774,9/14/2015 17:28:07,1737997588,9/14/2015 17:27:50,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,TUM treats ACID REFLUX,58,19,,69,22,treats,0.9950371902,213433,"antacids - nexium, [TUM]s, Pepcid AC, rolaids, etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,TUM,TWrex-treat
788211775,9/14/2015 16:09:01,1737957833,9/14/2015 16:08:40,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211775,9/14/2015 16:09:41,1737958159,9/14/2015 16:09:09,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211775,9/14/2015 16:21:10,1737963741,9/14/2015 16:20:46,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211775,9/14/2015 16:35:01,1737970362,9/14/2015 16:34:45,false,elite,0.25,33798502,USA,DE,"",108.59.8.218,CHRONIC MYELOGENOUS LEUKEMIA treats BUSULFAN,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211775,9/14/2015 16:44:40,1737975058,9/14/2015 16:44:16,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211775,9/14/2015 16:44:41,1737975070,9/14/2015 16:43:11,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211775,9/14/2015 16:45:09,1737975247,9/14/2015 16:44:32,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,BUSULFAN treats CHRONIC MYELOGENOUS LEUKEMIA,92,64,,120,72,treats,0.964901281354015,907521,"Hehlman R, Heimpel H, Hasford J et al. Randomized comparison of BUSULFAN and hydroxyurea in CHRONIC MYELOGENOUS LEUKEMIA: prolongation of survival by hydroxyurea",CHRONIC MYELOGENOUS LEUKEMIA,BUSULFAN,RO-may_treat
788211776,9/14/2015 14:50:01,1737920400,9/14/2015 14:47:14,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:50:09,1737920467,9/14/2015 14:49:36,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:51:25,1737920966,9/14/2015 14:50:12,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,MILK THISTLE treats CIRRHOSIS,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:51:39,1737921096,9/14/2015 14:51:08,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:51:44,1737921117,9/14/2015 14:51:07,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,CIRRHOSIS treats MILK THISTLE,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 14:54:53,1737922536,9/14/2015 14:52:03,false,neodev,0.7,11314968,CAN,BC,"",173.180.132.26,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211776,9/14/2015 15:02:10,1737925778,9/14/2015 15:01:09,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,no_relation,182,157,,190,169,treats,0.790569415042095,907669,"Alternative Therapies for Hepatitis     Normal; Alternative Therapies for Hepatitis  Therapy Best Evidencea Probably Usefulb Least Evidencec         Herbals MILK THISTLE (hepatitis, CIRRHOSIS 70 140 mg t.i.d.",CIRRHOSIS,MILK THISTLE,RO-may_treat
788211777,9/14/2015 17:19:26,1737993505,9/14/2015 17:19:02,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:22:34,1737995294,9/14/2015 17:21:21,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,SUSTAINED VENTRICULAR TACHYCARDIA treats SOTALOL,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:28:33,1737997747,9/14/2015 17:28:22,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:34:16,1738000540,9/14/2015 17:33:59,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:35:06,1738000952,9/14/2015 17:34:50,false,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:38:47,1738003192,9/14/2015 17:38:11,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:49:28,1738008218,9/14/2015 17:48:34,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.994134846772434,800319,"Evidence: • The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211778,9/14/2015 14:51:42,1737921111,9/14/2015 14:51:20,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,INTRAVENOUS DANTROLENE treats MALIGNANT HYPERTHERMIA,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211778,9/14/2015 14:52:47,1737921510,9/14/2015 14:52:34,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,INTRAVENOUS DANTROLENE treats MALIGNANT HYPERTHERMIA,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211778,9/14/2015 14:53:05,1737921657,9/14/2015 14:52:44,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,INTRAVENOUS DANTROLENE treats MALIGNANT HYPERTHERMIA,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211778,9/14/2015 14:53:49,1737922005,9/14/2015 14:52:51,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,INTRAVENOUS DANTROLENE treats MALIGNANT HYPERTHERMIA,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211778,9/14/2015 14:55:30,1737922787,9/14/2015 14:54:30,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,INTRAVENOUS DANTROLENE treats MALIGNANT HYPERTHERMIA,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211778,9/14/2015 14:56:18,1737923183,9/14/2015 14:55:53,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,MALIGNANT HYPERTHERMIA treats INTRAVENOUS DANTROLENE,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211778,9/14/2015 14:56:52,1737923514,9/14/2015 14:56:24,false,neodev,0.6012,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,INTRAVENOUS DANTROLENE treats MALIGNANT HYPERTHERMIA,39,87,,60,109,treats,0.424264068711929,908181,In one group of four pigs sensitive to MALIGNANT HYPERTHERMIA (MHS) a dose response to INTRAVENOUS DANTROLENE was determined by quantitation of toe twitch tension.,MALIGNANT HYPERTHERMIA,INTRAVENOUS DANTROLENE,RO-may_treat
788211779,9/14/2015 17:24:23,1737996032,9/14/2015 17:23:24,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211779,9/14/2015 17:29:12,1737998015,9/14/2015 17:28:59,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211779,9/14/2015 17:35:14,1738001028,9/14/2015 17:34:45,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211779,9/14/2015 17:40:11,1738003884,9/14/2015 17:39:29,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211779,9/14/2015 17:41:03,1738004270,9/14/2015 17:40:22,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211779,9/14/2015 17:43:53,1738005443,9/14/2015 17:41:19,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211779,9/14/2015 17:44:47,1738005914,9/14/2015 17:44:11,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,[RIBOFLAVIN] treats [MIGRAINE],75,0,,82,9,treats,0.997458699830735,213515,"[RIBOFLAVIN] has been rigorously studied and has demonstrated a reduction of [MIGRAINE] days and hours by 44%, although with no reduction in intensity of the headache.",[MIGRAINE],[RIBOFLAVIN],TWrex-treat
788211780,9/14/2015 15:21:40,1737934704,9/14/2015 15:21:33,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211780,9/14/2015 15:27:34,1737937121,9/14/2015 15:27:17,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211780,9/14/2015 15:30:13,1737938334,9/14/2015 15:30:06,false,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211780,9/14/2015 15:30:28,1737938446,9/14/2015 15:29:58,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211780,9/14/2015 15:30:47,1737938705,9/14/2015 15:24:19,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211780,9/14/2015 15:30:48,1737938723,9/14/2015 15:29:04,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211780,9/14/2015 15:31:45,1737939180,9/14/2015 15:30:42,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,SULFASALAZINE treats JUVENILE RHEUMATOID ARTHRITIS,84,52,,112,65,treats,1,804872,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE,TWrex-cause
788211781,9/14/2015 15:55:58,1737951385,9/14/2015 15:55:35,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211781,9/14/2015 16:08:39,1737957520,9/14/2015 16:08:27,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,no_relation,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211781,9/14/2015 16:09:08,1737957866,9/14/2015 16:08:21,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211781,9/14/2015 16:15:29,1737960575,9/14/2015 16:15:08,false,clixsense,0.8958,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,no_relation,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211781,9/14/2015 16:20:45,1737963563,9/14/2015 16:20:29,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211781,9/14/2015 16:33:39,1737969660,9/14/2015 16:33:03,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,no_relation,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211781,9/14/2015 16:34:42,1737970177,9/14/2015 16:33:56,false,elite,0.25,33798502,USA,DE,"",108.59.8.218,MIGRAINE treats HEADACHE,32,57,,40,65,treats,0.346410161513775,904695,"The history of the treatment of HEADACHE in general, and MIGRAINE in particular, spans the millennia, from the Neanderthal era to the Space Age",HEADACHE,MIGRAINE,RO-has_definitional_manifestation
788211782,9/14/2015 17:29:21,1737998062,9/14/2015 17:29:13,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:35:35,1738001244,9/14/2015 17:35:15,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:40:53,1738004164,9/14/2015 17:40:12,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:41:36,1738004481,9/14/2015 17:41:03,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:44:55,1738005998,9/14/2015 17:44:25,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:45:07,1738006111,9/14/2015 17:44:50,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211782,9/14/2015 17:46:05,1738006513,9/14/2015 17:43:53,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,FONDAPARINUX treats THROMBOEMBOLIC EVENTS,72,154,,92,166,treats,0.975900072948533,907030,"In the trial based analysis, fondaparinux was estimated to prevent 15.1 THROMBOEMBOLIC EVENTS per 1000 patients at three months compared with enoxaparin; FONDAPARINUX produced cost savings per patient at 30 days, 3 months, and 5 years postdischarge.",THROMBOEMBOLIC EVENTS,FONDAPARINUX,RO-may_prevent
788211783,9/14/2015 15:17:09,1737932495,9/14/2015 15:16:43,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,ARICEPT treats ALZHEIMER'S DISEASE,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211783,9/14/2015 15:20:54,1737934205,9/14/2015 15:20:40,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,ARICEPT treats ALZHEIMER'S DISEASE,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211783,9/14/2015 15:21:55,1737934859,9/14/2015 15:20:23,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,ARICEPT treats ALZHEIMER'S DISEASE,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211783,9/14/2015 15:22:57,1737935248,9/14/2015 15:21:53,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,ARICEPT treats ALZHEIMER'S DISEASE,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211783,9/14/2015 15:25:49,1737936375,9/14/2015 15:22:21,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,ALZHEIMER'S DISEASE treats ARICEPT,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211783,9/14/2015 15:26:26,1737936711,9/14/2015 15:25:45,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,ARICEPT treats ALZHEIMER'S DISEASE,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211783,9/14/2015 15:37:18,1737941958,9/14/2015 15:36:53,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,ARICEPT treats ALZHEIMER'S DISEASE,27,0,,46,7,treats,0.9974586998,222178,"[ARICEPT], normally used for [ALZHEIMER'S DISEASE], has been shown to improve executive functioning in CADASIL patients.",ALZHEIMER'S DISEASE,ARICEPT,TWrex-treat
788211784,9/14/2015 17:24:23,1737996027,9/14/2015 17:23:24,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:29:12,1737998016,9/14/2015 17:28:59,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:35:14,1738001026,9/14/2015 17:34:45,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:40:11,1738003890,9/14/2015 17:39:29,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:41:03,1738004258,9/14/2015 17:40:22,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:43:53,1738005442,9/14/2015 17:41:19,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:44:47,1738005920,9/14/2015 17:44:11,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.983869910099907,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211785,9/14/2015 17:46:56,1738006894,9/14/2015 17:46:38,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211785,9/14/2015 17:55:27,1738011612,9/14/2015 17:54:57,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211785,9/14/2015 17:55:37,1738011721,9/14/2015 17:54:25,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211785,9/14/2015 17:56:53,1738012397,9/14/2015 17:56:11,false,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211785,9/14/2015 18:02:21,1738015048,9/14/2015 18:01:46,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211785,9/14/2015 18:12:56,1738020902,9/14/2015 18:12:32,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211785,9/14/2015 18:21:35,1738025327,9/14/2015 18:20:01,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,BAPINEUZUMAB treats ALZHEIMER'S DISEASE,109,92,,128,104,treats,0.9138115486,208136,title = Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of [BAPINEUZUMAB] for [ALZHEIMER'S DISEASE].,ALZHEIMER'S DISEASE,BAPINEUZUMAB,TWrex-treat
788211786,9/14/2015 17:35:59,1738001493,9/14/2015 17:35:35,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,ATROPINE treats BRADYCARDIA,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211786,9/14/2015 17:41:24,1738004418,9/14/2015 17:40:54,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,ATROPINE treats BRADYCARDIA,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211786,9/14/2015 17:45:16,1738006137,9/14/2015 17:44:58,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,BRADYCARDIA treats ATROPINE,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211786,9/14/2015 17:45:36,1738006341,9/14/2015 17:45:10,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,no_relation,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211786,9/14/2015 17:49:59,1738008552,9/14/2015 17:47:13,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,BRADYCARDIA treats ATROPINE,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211786,9/14/2015 17:49:59,1738008556,9/14/2015 17:46:06,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,ATROPINE treats BRADYCARDIA,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211786,9/14/2015 17:53:25,1738010616,9/14/2015 17:52:16,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,ATROPINE treats BRADYCARDIA,233,203,,244,211,treats,0.928279121632914,907917,"Maintenance of airway, breathing, and circulation; fluids and vasopressors for hypotension; multiple dose activated charcoal; calcium chloride or calcium gluconate for hypotension and bradydysrhythmias, ATROPINE or isoproterenol for BRADYCARDIA",BRADYCARDIA,ATROPINE,RO-may_treat
788211787,9/14/2015 17:45:55,1738006454,9/14/2015 17:45:38,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:46:01,1738006488,9/14/2015 17:45:52,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:51:09,1738009196,9/14/2015 17:50:44,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:53:18,1738010576,9/14/2015 17:51:55,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:54:27,1738011074,9/14/2015 17:52:54,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:54:54,1738011297,9/14/2015 17:53:02,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:55:12,1738011455,9/14/2015 17:53:55,false,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211788,9/14/2015 15:04:27,1737926719,9/14/2015 15:04:07,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211788,9/14/2015 15:09:22,1737928835,9/14/2015 15:08:39,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211788,9/14/2015 15:09:31,1737928906,9/14/2015 15:07:26,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211788,9/14/2015 15:13:13,1737930509,9/14/2015 15:13:01,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211788,9/14/2015 15:14:22,1737930965,9/14/2015 15:13:35,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211788,9/14/2015 15:15:25,1737931453,9/14/2015 15:15:05,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211788,9/14/2015 15:19:05,1737933478,9/14/2015 15:17:54,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,[ORAL ANTIHISTAMINES] treats [ITCHING],66,28,,72,46,treats,0.928279121632914,207687,Topical corticosteroids and [ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[ORAL ANTIHISTAMINES],TWrex-treat
788211789,9/14/2015 15:42:39,1737944401,9/14/2015 15:42:21,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211789,9/14/2015 15:44:49,1737945314,9/14/2015 15:44:02,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,no_relation,51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211789,9/14/2015 15:52:11,1737949481,9/14/2015 15:51:53,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211789,9/14/2015 15:53:13,1737950006,9/14/2015 15:52:47,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,[GEMTUZUMAB OZOGAMICIN MYLOTARG] treats [ACUTE MYELOGENOUS LEUKEMIA],51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211789,9/14/2015 15:54:50,1737950829,9/14/2015 15:54:26,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211789,9/14/2015 16:07:14,1737956852,9/14/2015 16:06:09,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211789,9/14/2015 16:20:01,1737962808,9/14/2015 16:19:31,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,51,0,,76,29,treats,0.433012701892219,223028,[GEMTUZUMAB OZOGAMICIN MYLOTARG] 2000 humanized CD33 [ACUTE MYELOGENOUS LEUKEMIA] .,[ACUTE MYELOGENOUS LEUKEMIA],[GEMTUZUMAB OZOGAMICIN MYLOTARG],TWrex-treat
788211790,9/14/2015 14:50:27,1737920600,9/14/2015 14:50:09,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:50:56,1737920768,9/14/2015 14:50:02,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:51:58,1737921192,9/14/2015 14:51:39,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:52:04,1737921240,9/14/2015 14:51:45,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:52:06,1737921263,9/14/2015 14:51:26,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:54:35,1737922388,9/14/2015 14:53:56,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:56:23,1737923238,9/14/2015 14:53:20,false,neodev,0.6012,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,no_relation,88,14,,121,25,treats,0.928279121632914,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211791,9/14/2015 15:05:10,1737927066,9/14/2015 15:04:28,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211791,9/14/2015 15:10:11,1737929077,9/14/2015 15:09:23,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211791,9/14/2015 15:13:31,1737930651,9/14/2015 15:13:14,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211791,9/14/2015 15:15:00,1737931259,9/14/2015 15:14:23,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211791,9/14/2015 15:15:18,1737931393,9/14/2015 15:11:41,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211791,9/14/2015 15:16:17,1737931961,9/14/2015 15:15:25,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211791,9/14/2015 15:20:22,1737933973,9/14/2015 15:18:41,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,no_relation,178,211,,184,219,treats,0.377964473009227,814531,"COMMENTARY  In a very diverse group of patients, with equally diverse risks for seizure recurrence, Marson and colleagues compared early and deferred AED treatment after a first SEIZURE or an early diagnosis of EPILEPSY",SEIZURE,EPILEPSY,TWrex-cause
788211792,9/14/2015 14:51:42,1737921110,9/14/2015 14:51:20,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211792,9/14/2015 14:52:47,1737921511,9/14/2015 14:52:34,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211792,9/14/2015 14:53:05,1737921655,9/14/2015 14:52:44,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211792,9/14/2015 14:53:49,1737922004,9/14/2015 14:52:51,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211792,9/14/2015 14:55:30,1737922790,9/14/2015 14:54:30,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211792,9/14/2015 14:56:18,1737923182,9/14/2015 14:55:53,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211792,9/14/2015 14:56:52,1737923506,9/14/2015 14:56:24,false,neodev,0.6012,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,1 MG DEXAMETHASONE SUPPRESSION treats CUSHING'S SYNDROME,26,76,,43,117,treats,0.348742916231458,803065,"• In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
788211793,9/14/2015 16:09:01,1737957828,9/14/2015 16:08:40,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,PIRACETAM treats APHASIA,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211793,9/14/2015 16:09:41,1737958162,9/14/2015 16:09:09,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,PIRACETAM treats APHASIA,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211793,9/14/2015 16:21:10,1737963743,9/14/2015 16:20:46,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,PIRACETAM treats APHASIA,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211793,9/14/2015 16:35:01,1737970361,9/14/2015 16:34:45,false,elite,0.25,33798502,USA,DE,"",108.59.8.218,no_relation,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211793,9/14/2015 16:44:41,1737975057,9/14/2015 16:43:11,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,PIRACETAM treats APHASIA,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211793,9/14/2015 16:44:40,1737975069,9/14/2015 16:44:16,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,PIRACETAM treats APHASIA,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211793,9/14/2015 16:45:09,1737975249,9/14/2015 16:44:32,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,PIRACETAM treats APHASIA,89,0,,96,9,treats,0.968495997,218547,"[PIRACETAM] has been found to improve cognition after stroke, and reduce symptoms, such as [APHASIA].",APHASIA,PIRACETAM,TWrex-treat
788211794,9/14/2015 15:10:53,1737929389,9/14/2015 15:10:12,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211794,9/14/2015 15:14:04,1737930858,9/14/2015 15:13:49,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211794,9/14/2015 15:15:36,1737931561,9/14/2015 15:15:01,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211794,9/14/2015 15:16:42,1737932206,9/14/2015 15:16:18,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211794,9/14/2015 15:17:16,1737932558,9/14/2015 15:15:24,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211794,9/14/2015 15:20:39,1737934088,9/14/2015 15:19:42,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211794,9/14/2015 15:21:52,1737934823,9/14/2015 15:19:06,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,ZIDOVUDINE treats ADVANCED AIDS RELATED COMPLEX,95,50,,123,60,treats,0.987829161147262,800374,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE,TWrex-cause
788211795,9/14/2015 18:25:24,1738027620,9/14/2015 18:24:52,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 18:28:07,1738029076,9/14/2015 18:26:38,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 18:35:23,1738033583,9/14/2015 18:35:00,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 18:38:29,1738036208,9/14/2015 18:37:00,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 19:23:53,1738101551,9/14/2015 19:23:29,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 19:27:39,1738107406,9/14/2015 19:26:22,false,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211795,9/14/2015 19:28:21,1738108159,9/14/2015 19:26:48,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,[INTRA ARTERIAL IODINE 131 LIPIODOL] treats [PORTAL VEIN THROMBUS],109,0,,129,33,treats,0.995037190209989,214211,"[INTRA ARTERIAL IODINE 131 LIPIODOL] administration Efficacy demonstrated in unresectable patients, those with [PORTAL VEIN THROMBUS]",[PORTAL VEIN THROMBUS],[INTRA ARTERIAL IODINE 131 LIPIODOL],TWrex-treat
788211796,9/14/2015 17:55:40,1738011734,9/14/2015 17:55:29,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,S PANAMA BACTEREMIA treats BACTERIA,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211796,9/14/2015 18:02:35,1738015118,9/14/2015 18:02:23,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,S PANAMA BACTEREMIA treats BACTERIA,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211796,9/14/2015 18:14:27,1738021693,9/14/2015 18:12:58,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,no_relation,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211796,9/14/2015 18:22:21,1738025702,9/14/2015 18:21:36,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,BACTERIA treats S PANAMA BACTEREMIA,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211796,9/14/2015 18:24:47,1738027191,9/14/2015 18:23:31,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211796,9/14/2015 18:25:53,1738027871,9/14/2015 18:25:42,false,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,BACTERIA treats S PANAMA BACTEREMIA,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211796,9/14/2015 19:23:07,1738100622,9/14/2015 19:22:29,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,no_relation,32,71,,39,90,treats,0.365148371670111,903807,"As to bacteriological efficacy, BACTERIA were reduced in the case with S PANAMA BACTEREMIA while they were eradicated within 2 to 5 days after CTRX administration in 2 cases with acute urinary tract infections and 1 with recurrent urinary tract infection, both caused with E. coli, and in 1 with acute urinary tract infection with P. mirabilis.",BACTERIA,S PANAMA BACTEREMIA,RO-has_causative_agent
788211797,9/14/2015 18:25:24,1738027622,9/14/2015 18:24:52,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 18:28:07,1738029074,9/14/2015 18:26:38,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 18:35:23,1738033584,9/14/2015 18:35:00,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 18:38:29,1738036209,9/14/2015 18:37:00,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 19:23:53,1738101552,9/14/2015 19:23:29,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 19:27:39,1738107407,9/14/2015 19:26:22,false,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211797,9/14/2015 19:28:21,1738108156,9/14/2015 19:26:48,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,PAPAVERINE treats ERECTILE DYSFUNCTION,84,121,,103,131,treats,0.629940788348712,906676,To evaluate the use of papaverine induced erection as a diagnostic test in men with ERECTILE DYSFUNCTION 24 patients had PAPAVERINE injected into the corpus cavernosum.,ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
788211798,9/14/2015 15:45:11,1737945469,9/14/2015 15:44:50,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211798,9/14/2015 15:52:28,1737949604,9/14/2015 15:52:12,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211798,9/14/2015 15:55:33,1737951197,9/14/2015 15:54:51,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211798,9/14/2015 16:08:19,1737957377,9/14/2015 16:07:15,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211798,9/14/2015 16:08:25,1737957445,9/14/2015 16:07:49,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211798,9/14/2015 16:15:07,1737960496,9/14/2015 16:14:18,false,clixsense,0.8958,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211798,9/14/2015 16:20:28,1737963489,9/14/2015 16:20:02,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,57,25,,69,33,treats,0.916698497028211,219557,"For example, any form of [NICOTINE] hinders the process of [BONE HEALING], and adequate nutrition will help the bone healing process.",BONE HEALING,NICOTINE,TWrex-treat
788211799,9/14/2015 17:19:26,1737993499,9/14/2015 17:19:02,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:22:34,1737995293,9/14/2015 17:21:21,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:28:33,1737997744,9/14/2015 17:28:22,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:34:16,1738000537,9/14/2015 17:33:59,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:35:06,1738000983,9/14/2015 17:34:50,false,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:38:47,1738003190,9/14/2015 17:38:11,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211799,9/14/2015 17:49:28,1738008216,9/14/2015 17:48:34,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,ASPIRIN treats MYOCARDIAL INFARCTION,272,209,,293,216,treats,0.938314863256837,907118,Studies in patients scheduled for percutaneous coronary intervention and those with unstable angina or non-Q-wave myocardial infarction have shown that a combination of intravenous GP IIb-IIIa inhibitors with ASPIRIN and heparin is associated with a reduction in death or MYOCARDIAL INFARCTION compared with therapy with aspirin and heparin alone,MYOCARDIAL INFARCTION,ASPIRIN,RO-may_prevent
788211800,9/14/2015 16:46:57,1737976082,9/14/2015 16:46:41,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 16:48:57,1737977279,9/14/2015 16:47:43,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:06:21,1737986884,9/14/2015 17:06:14,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:18:43,1737992993,9/14/2015 17:18:29,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:20:02,1737993876,9/14/2015 17:18:59,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:24:13,1737995962,9/14/2015 17:23:22,false,clixsense,0.9286,21490235,GBR,N7,Woking,86.30.254.232,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:25:01,1737996289,9/14/2015 17:24:43,false,instagc,0.9286,13581319,USA,IL,Trenton,208.70.36.12,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211801,9/14/2015 15:42:19,1737944272,9/14/2015 15:41:43,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211801,9/14/2015 15:44:01,1737945021,9/14/2015 15:43:35,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211801,9/14/2015 15:51:52,1737949283,9/14/2015 15:51:29,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211801,9/14/2015 15:52:43,1737949725,9/14/2015 15:52:12,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211801,9/14/2015 15:54:23,1737950635,9/14/2015 15:53:47,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211801,9/14/2015 16:06:08,1737956338,9/14/2015 16:05:05,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211801,9/14/2015 16:07:48,1737957125,9/14/2015 16:07:17,false,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,SODIUM OXYBATE treats CATAPLEXY,221,0,,229,14,treats,0.991836598134175,803797,"SODIUM OXYBATE which is more commonly known as Œ≥ hydroxybutyrate (GHB), was once classified as a schedule I control substance but has been approved recently by the Food and Drug Administration (FDA) for the treatment of CATAPLEXY.",CATAPLEXY,SODIUM OXYBATE,TWrex-cause
788211802,9/14/2015 16:46:57,1737976083,9/14/2015 16:46:41,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211802,9/14/2015 16:48:57,1737977284,9/14/2015 16:47:43,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,no_relation,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211802,9/14/2015 17:06:21,1737986887,9/14/2015 17:06:14,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,PPD treats TB,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211802,9/14/2015 17:18:43,1737992998,9/14/2015 17:18:29,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,PPD treats TB,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211802,9/14/2015 17:20:02,1737993889,9/14/2015 17:18:59,false,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,PPD treats TB,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211802,9/14/2015 17:24:13,1737995966,9/14/2015 17:23:22,false,clixsense,0.9286,21490235,GBR,N7,Woking,86.30.254.232,PPD treats TB,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211802,9/14/2015 17:25:01,1737996291,9/14/2015 17:24:43,false,instagc,0.9286,13581319,USA,IL,Trenton,208.70.36.12,PPD treats TB,3,22,,4,25,treats,0.361157559257308,906829,"If TB is a concern, a PPD is performed.",TB,PPD,RO-may_diagnose
788211803,9/14/2015 17:55:40,1738011731,9/14/2015 17:55:29,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:02:35,1738015117,9/14/2015 18:02:23,false,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,ALZHEIMER DISEASE treats VALSARTAN,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:14:27,1738021694,9/14/2015 18:12:58,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:22:21,1738025693,9/14/2015 18:21:36,false,neodev,0.6401,33011398,USA,DE,"",108.59.8.208,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:24:47,1738027196,9/14/2015 18:23:31,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:25:53,1738027874,9/14/2015 18:25:42,false,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,no_relation,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 19:23:07,1738100646,9/14/2015 19:22:29,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211804,9/14/2015 14:50:58,1737920784,9/14/2015 14:50:28,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,[2 HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211804,9/14/2015 14:51:38,1737921093,9/14/2015 14:50:57,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,[2 HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211804,9/14/2015 14:52:20,1737921359,9/14/2015 14:51:59,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,[2 HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211804,9/14/2015 14:52:26,1737921390,9/14/2015 14:52:05,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,[2 HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211804,9/14/2015 14:53:17,1737921724,9/14/2015 14:52:07,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,[2 HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211804,9/14/2015 14:55:17,1737922707,9/14/2015 14:54:36,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,[STROKE] treats [2 HOMOCYSTEINE LOWERING VITAMINS],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211804,9/14/2015 15:05:58,1737927350,9/14/2015 15:05:10,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,[2 HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,13,,73,44,treats,0.866025403784439,209425,"A trial with [2 HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[2 HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788211805,9/14/2015 17:41:48,1738004564,9/14/2015 17:41:25,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,no_relation,91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:45:37,1738006351,9/14/2015 17:45:17,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:45:49,1738006404,9/14/2015 17:45:38,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:50:43,1738009009,9/14/2015 17:49:29,false,neodev,0.75,20306047,GBR,"","",80.41.0.252,no_relation,91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:51:54,1738009612,9/14/2015 17:50:56,false,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:52:53,1738010263,9/14/2015 17:51:14,false,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,[VENIPUNCTURE] treats [SCARRING],91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211805,9/14/2015 17:53:01,1738010393,9/14/2015 17:50:01,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,no_relation,91,62,,99,73,treats,0.753778361444409,222455,Anecdotal reports have said that rubbing Vitamin E oil on the [VENIPUNCTURE] site may reduce [SCARRING],[SCARRING],[VENIPUNCTURE],TWrex-treat
788211806,9/14/2015 15:10:53,1737929393,9/14/2015 15:10:12,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:14:04,1737930861,9/14/2015 15:13:49,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:15:36,1737931560,9/14/2015 15:15:01,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:16:42,1737932208,9/14/2015 15:16:18,false,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:17:16,1737932554,9/14/2015 15:15:24,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:20:39,1737934097,9/14/2015 15:19:42,false,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:21:52,1737934837,9/14/2015 15:19:06,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211807,9/14/2015 17:29:21,1737998063,9/14/2015 17:29:13,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:35:35,1738001245,9/14/2015 17:35:15,false,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:40:53,1738004166,9/14/2015 17:40:12,false,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:41:36,1738004482,9/14/2015 17:41:03,false,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:44:55,1738005997,9/14/2015 17:44:25,false,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,HELICOBACTER PYLORI treats ALLICIN,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:45:07,1738006112,9/14/2015 17:44:50,false,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211807,9/14/2015 17:46:05,1738006512,9/14/2015 17:43:53,false,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,ALLICIN treats HELICOBACTER PYLORI,47,98,,66,105,treats,0.983078304622849,205484,"It is also acts against the stomach ulcer germ [HELICOBACTER PYLORI], however not as efficiently as [ALLICIN].",HELICOBACTER PYLORI,ALLICIN,TWrex-treat
788211808,9/14/2015 15:42:39,1737944406,9/14/2015 15:42:21,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211808,9/14/2015 15:44:49,1737945312,9/14/2015 15:44:02,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211808,9/14/2015 15:52:11,1737949477,9/14/2015 15:51:53,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211808,9/14/2015 15:53:13,1737950008,9/14/2015 15:52:47,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211808,9/14/2015 15:54:50,1737950826,9/14/2015 15:54:26,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211808,9/14/2015 16:07:14,1737956853,9/14/2015 16:06:09,false,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211808,9/14/2015 16:20:01,1737962809,9/14/2015 16:19:31,false,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,CONCOMITANT DROTRECOGIN ALFA treats SEPSIS,162,68,,167,96,treats,0.889000889001333,803685,"Levy M, Levi M, Williams MD et al. Comprehensive safety analysis of CONCOMITANT DROTRECOGIN ALFA (activated) and prophylactic heparin use in patients with severe SEPSIS",SEPSIS,CONCOMITANT DROTRECOGIN ALFA,TWrex-cause
788211809,9/14/2015 15:33:12,1737940011,9/14/2015 15:32:55,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211809,9/14/2015 15:39:07,1737942765,9/14/2015 15:38:17,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211809,9/14/2015 15:41:20,1737943742,9/14/2015 15:41:07,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211809,9/14/2015 15:43:10,1737944672,9/14/2015 15:42:30,false,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211809,9/14/2015 15:47:14,1737946553,9/14/2015 15:46:59,false,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211809,9/14/2015 15:50:56,1737948804,9/14/2015 15:50:21,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211809,9/14/2015 15:53:06,1737949983,9/14/2015 15:52:23,false,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,BASAL INSULIN GLARGINE treats TYPE 2 DIABETES,105,42,,119,64,treats,0.924500327042048,800895,2010 06 26  Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,TYPE 2 DIABETES,BASAL INSULIN GLARGINE,TWrex-cause
788211810,9/14/2015 14:50:58,1737920781,9/14/2015 14:50:28,false,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:51:38,1737921094,9/14/2015 14:50:57,false,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:52:20,1737921360,9/14/2015 14:51:59,false,elite,0.8333,31883685,GBR,"","",79.66.254.237,no_relation,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:52:26,1737921389,9/14/2015 14:52:05,false,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:53:17,1737921729,9/14/2015 14:52:07,false,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:55:17,1737922708,9/14/2015 14:54:36,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 15:05:58,1737927349,9/14/2015 15:05:10,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.431331092813754,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211811,9/14/2015 19:29:38,1738109862,9/14/2015 19:29:20,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:36:59,1738120144,9/14/2015 19:36:39,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:47:17,1738133894,9/14/2015 19:46:38,false,clixsense,0.8333,21665495,CAN,"","",24.105.69.70,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:54:29,1738142783,9/14/2015 19:53:02,false,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 19:56:20,1738144933,9/14/2015 19:53:39,false,neodev,0.7,11658682,CAN,BC,Smithers,50.98.182.88,no_relation,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 20:00:21,1738149954,9/14/2015 19:59:26,false,elite,0.8,29768955,GBR,C3,Gamlingay,31.50.187.165,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211811,9/14/2015 20:39:51,1738222284,9/14/2015 20:39:20,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,ANTI-DEPRESSANT treats NUTCRACKER ESOPHAGUS,141,23,,161,38,treats,0.979957887,207551,"Finally, trazodone, an [ANTI-DEPRESSANT] that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,ANTI-DEPRESSANT,TWrex-treat
788211812,9/14/2015 15:28:15,1737937448,9/14/2015 15:27:53,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:31:21,1737939040,9/14/2015 15:30:57,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:32:38,1737939691,9/14/2015 15:32:12,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:33:17,1737940083,9/14/2015 15:32:16,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:37:54,1737942331,9/14/2015 15:37:19,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:40:35,1737943421,9/14/2015 15:39:59,false,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:49:31,1737947927,9/14/2015 15:41:15,false,neodev,0.5595,33761260,USA,DE,"",108.59.8.210,[PARURESIS] treats [CATHETERIZATION],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211813,9/14/2015 15:27:52,1737937255,9/14/2015 15:27:35,false,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,ENOXAPARIN treats VENOUS THROMBOEMBOLISM,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211813,9/14/2015 15:30:55,1737938781,9/14/2015 15:30:28,false,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,ENOXAPARIN treats VENOUS THROMBOEMBOLISM,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211813,9/14/2015 15:32:12,1737939402,9/14/2015 15:31:45,false,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211813,9/14/2015 15:32:15,1737939424,9/14/2015 15:30:49,false,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,ENOXAPARIN treats VENOUS THROMBOEMBOLISM,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211813,9/14/2015 15:36:15,1737941544,9/14/2015 15:31:50,false,clixsense,0.7252,21875134,GBR,"","",80.189.12.98,ENOXAPARIN treats VENOUS THROMBOEMBOLISM,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211813,9/14/2015 15:36:36,1737941674,9/14/2015 15:30:48,false,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,ENOXAPARIN treats VENOUS THROMBOEMBOLISM,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211813,9/14/2015 15:36:52,1737941774,9/14/2015 15:35:59,false,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,no_relation,57,28,,78,38,treats,1,805032,"Dabigatran etexilate versus ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM after total hip replacement: a randomised, double blind, non inferiority trial.",VENOUS THROMBOEMBOLISM,ENOXAPARIN,TWrex-cause
788211814,9/14/2015 14:57:00,1737923555,9/14/2015 14:56:42,false,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 14:58:13,1737924064,9/14/2015 14:57:08,false,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:02:36,1737925921,9/14/2015 15:01:44,false,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:08:38,1737928545,9/14/2015 15:07:07,false,neodev,0.7986,33758777,USA,"","",38.95.108.251,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:11:14,1737929540,9/14/2015 15:10:24,false,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:11:38,1737929745,9/14/2015 15:09:37,false,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211814,9/14/2015 15:13:47,1737930718,9/14/2015 15:13:31,false,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,INJECTION SITE treats PAIN,625,617,,638,621,treats,0.420084025208403,802190,"Oral availability and safety should rapidly make it the preferred agent Influenza virus vaccine  Induces protective antibodies against influenza  0.5 mL im yearly  Prevents influenza, in turn preventing worsened anemia due to infection and complications of superinfections  Fever and sore arm in  Give to all patients with hemolytic anemias Pneumococcal polysaccharide vaccine  Develops antibodies to pneumococcal antigens  0.5 mL im every 5 6 years  Can prevent the most common form of overwhelming postsplenectomy sepsis; prevents worsened anemia and severe infection in all hemolytic anemia patients  Erythema and PAIN at INJECTION SITE in 50%; systemic fever in.",INJECTION SITE,PAIN,TWrex-cause
788211815,9/14/2015 16:46:39,1737975955,9/14/2015 16:46:10,false,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211815,9/14/2015 16:47:41,1737976601,9/14/2015 16:46:32,false,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,no_relation,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211815,9/14/2015 16:49:39,1737977765,9/14/2015 16:49:30,false,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,PHEOCHROMOCYTOMA treats HYPERTENSION,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211815,9/14/2015 17:06:13,1737986825,9/14/2015 17:05:59,false,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,PHEOCHROMOCYTOMA treats HYPERTENSION,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211815,9/14/2015 17:13:01,1737990194,9/14/2015 17:12:54,false,superrewards,0.8583,33199643,USA,WI,La Crosse,138.49.1.27,PHEOCHROMOCYTOMA treats HYPERTENSION,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211815,9/14/2015 17:18:28,1737992867,9/14/2015 17:18:00,false,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,PHEOCHROMOCYTOMA treats HYPERTENSION,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211815,9/14/2015 17:28:07,1737997585,9/14/2015 17:27:50,false,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,no_relation,194,91,,206,107,treats,0.372104203767625,902961,This case demonstrates a typical presentation of pheochromocytoma and the need to consider PHEOCHROMOCYTOMA early in the differential diagnosis of hypertensive emergency or difficult to control HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
788211816,9/14/2015 18:28:29,1738029263,9/14/2015 18:28:08,false,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 18:35:54,1738033845,9/14/2015 18:35:24,false,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 18:38:46,1738036494,9/14/2015 18:38:31,false,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:24:11,1738102023,9/14/2015 19:23:54,false,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:28:14,1738108031,9/14/2015 19:27:41,false,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:28:57,1738108940,9/14/2015 19:28:44,false,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,[HIV RELATED PML] treats [MEFLOQUINE],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:35:16,1738117585,9/14/2015 19:34:53,false,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
